Flavoured Nicotine Powder Inhaler for Low-Flow Dose Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing dry powder inhalers (DPIs) require high inhalation rates (40-120 L/min) to deliver pharmaceutical powders deep into the lungs, leading to incomplete de-aggregation and deposition in upper airways, and are not suitable for delivering flavoured nicotine at conventional smoking regime inhalation rates.
Innovation Solution
A flavoured nicotine powder inhaler with a simplified configuration and airflow path, capable of delivering nicotine powder at low inhalation rates (≤5 L/min) using a carrier-free formulation and a flavour delivery element, allowing simultaneous delivery of nicotine and flavour at conventional smoking regime inhalation rates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If conventional DPIs use high inhalation rates (40-120 L/min) to deliver pharmaceutical powders deep into the lungs, then particle delivery to lower airways is improved, but the device becomes unsuitable for conventional smoking regime inhalation rates and requires complex de-aggregation mechanisms
Solution Approach 1:
The invention segments the powder delivery system by using pre-formed small particles (1-5 micrometers) that do not require de-aggregation, eliminating the need for complex grinding or impact mechanisms used in conventional DPIs. The nicotine powder is supplied as fine particles directly suitable for lung delivery.
Solution Approach 2:
Instead of using large carrier particles that need to be broken down (conventional approach), the invention inverts the approach by using small nicotine particles as the primary delivery form, eliminating the need for de-aggregation mechanisms entirely.
2Quantity of substance
If conventional DPIs use large carrier particles (20-100 micrometers) with agglomerated API, then powder can be delivered at high flow rates, but incomplete de-aggregation occurs and API remains deposited in upper airways
Solution Approach 1:
The invention uses pre-segmented small particles (1-5 micrometers) of nicotine powder that are already in the optimal size range for lung delivery, eliminating the need for complex de-aggregation processes and ensuring complete particle delivery to lower airways.
Solution Approach 2:
The invention extracts the nicotine from its conventional large particle or agglomerated form and delivers it in a purified small particle form (1-5 micrometers), removing the need for carrier particles and complex de-aggregation mechanisms.
3Reliability
If DPIs are designed to deliver dry powder deep into lungs at high inhalation rates, then therapeutic delivery is improved, but the device size and configuration differ significantly from conventional cigarettes
Solution Approach 1:
The invention extracts the essential function of nicotine delivery from the bulky conventional DPI design, creating a compact device that mimics cigarette size and configuration while maintaining reliable dose delivery through its simplified airflow path.
Solution Approach 2:
Instead of making the inhaler larger and more complex to ensure reliable delivery (conventional approach), the invention inverts the approach by using pre-formed small particles that require simpler delivery mechanisms, enabling compact device design.
4Measurement precision
If conventional DPIs require high inhalation rates (40-120 L/min) for complete powder disaggregation, then dosing accuracy is improved, but the device is unsuitable for users with impaired breathing conditions
Solution Approach 1:
The invention uses pre-segmented small particles (1-5 micrometers) that do not require high inhalation rates for de-aggregation, enabling accurate dosing delivery even at low inhalation rates typical of users with impaired breathing conditions.
Solution Approach 2:
The small particle design allows the powder to be delivered passively through normal breathing without requiring the user to generate high inhalation flows, making the device self-adapting to users with various breathing capabilities.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Delivers a predictable and metered dose of flavoured nicotine and optional active ingredients at low inhalation rates, suitable for users with impaired breathing conditions, mimicking conventional smoking experience.
Implementation Method 1
An airflow channel extends along the body of the inhaler. The dose of nicotine powder can be inhaled into lungs of a user at an inhalation rate of less than about 5 L/min
Implementation Method 2
A flavour delivery element is in fluid communication with the airflow channel. The flavourant can be a dry powder or a liquid flavourant.
Data Source
AI summary
This disclosure relates to flavoured nicotine powder inhalers where the nicotine powder is delivered at air flow rates that mimic a smoking regime.


